Mingshuang Li

Mingshuang Li

Auto-generated profile, based on publicly available information

Mingshuang Li

Respiratory Department, Taizhou Hospital, Shanghai University of Traditional Chinese Medicine, Taizhou, Zhejiang, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2023 in Medicine
Verified
Journal Article
Open access
CRConglin Ren
Conglin Ren
MLMingshuang Li
Mingshuang Li
Background: A large body of research has investigated the use of statins in rheumatoid arthritis (RA); however, the therapeutic effects of statins remain uncertain. Thus, we designed a systematic review and meta-analysis to evaluate the role of statins in patients with RA. Methods: Databases searched to detect clinical randomized controlled trials or clinical controlled trials on the interaction between statins and RA before January 2020 included PubMed, Web of Sciences, Embase, Cochrane Library, CNKI, Wan Fang Database. Efficacy was measured by Disease Activity Score in 28 Joints (DAS28), erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), tenderness of the joint (TJ), swelling of the joint (SJ), and interleukin-6. The level of blood lipid was also evaluated. STATA 12.0 was used for the meta-analysis. The Cochrane method was used for quality assessment. Heterogeneity was considered to determine fixed effects or random effects models. Results: Nineteen clinical trials with a total of 22,906 subjects were included in the meta-analysis. Sixteen studies reported a change in DAS28 after statin treatment. The pooled analysis showed that statins reduced DAS28 in RA patients. Change in ESR after statin treatment was reported in 9 studies. The summary analysis showed that statins lowered ESR in RA patients. Twelve studies reported a change in CRP after statin treatment. The results of the entire analysis showed that statins lowered CRP in RA patients. Seven studies reported a change in TJ after statin treatment. The combined analysis showed that statins reduced TJ at RA patients. Six studies reported changes in IL6 after statin therapy. The results showed that statins failed to reduce IL6 in RA patients. Seven studies reported changes in SJ after statin therapy, which showed that statins failed to reduce SJ in RA patients. We also found that statins can reduce blood lipid levels in RA patients. Conclusion: In conclusion, statins were able to reduce DAS28, ESR, CRP, TJ, and blood lipids. It indicated that stains can benefit patients with RA by inhibiting the expression of inflammatory factors and reducing the levels of lipids in the blood. Our study may offer a new perspective on the treatment of RA and provide research ideas for future larger multi-center clinical trials.

3 October 2022 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
PDF file
MLMingshuang Li
Mingshuang Li
CRConglin Ren
Conglin Ren
Background: Baicalin is a generally available flavonoid with potent biological activity. The present study aimed to assess the underlying mechanism of baicalin in treatment of atherosclerosis (AS) with the help of network pharmacology, molecular docking and experimental validation. Methods: The target genes of baicalin and AS were identified from public databases, and the overlapping results were considered to be baicalin-AS targets. Core target genes of baicalin were obtained through the PPI network and validated by a clinical microarray dataset (GSE132651). Human aortic endothelial cells (HAECs) were treated with Lipopolysaccharide (LPS) to construct an endothelial injury model. The expression of NOX4 was examined by real-time qPCR and western blot. Flow cytometry was used to detect intracellular levels of reactive oxygen species (ROS). Furthermore, HAECs were transfected with NOX4-specific siRNA and then co-stimulated with baicalin and LPS to investigate whether NOX4 was involved in the anti-oxidative stress effects of baicalin. Results: In this study, baicalin had 45 biological targets against AS. Functional enrichment analysis demonstrated that most targets were involved in oxidative stress. Using the CytoHubba plug-in, we obtained the top 10 genes in the PPI network ranked by the EPC algorithm. Molecular docking and microarray dataset validation indicated that NOX4 may be an essential target of baicalin, and its expression was significantly suppressed in AS samples compared to controls. In endothelial injury model, intervention of HAECs with baicalin increased the expression levels of NOX4 and NOS3 (eNOS), and decreased LPS-induced ROS generation. After inhibition of NOX4, the anti-ROS-generating effect of baicalin was abolished. Conclusion: Collectively, we combined network pharmacology and endothelial injury models to investigate the anti-AS mechanism of baicalin. The results demonstrate that baicalin may exert anti-oxidative stress effects by targeting NOX4, providing new mechanisms and insights to baicalin for the treatment of AS.

6 November 2020 in Cardiology Research and Practice
Verified
Journal Article
Open access
PDF file
MLMingshuang Li
Mingshuang Li
CRConglin Ren
Conglin Ren
CWChenxia Wu
Chenxia Wu
XLXinyao Li
Xinyao Li
XLXinyi Li
Xinyi Li
WMWei Mao
Wei Mao
Background. Acute coronary syndrome (ACS) has a high incidence and mortality rate. Early detection and intervention would provide clinical benefits. This study aimed to reveal hub genes, transcription factors (TFs), and microRNAs (miRNAs) that affect plaque stability and provide the possibility for the early diagnosis and treatment of ACS. Methods. We obtained gene expression matrix GSE19339 for ACS patients and healthy subjects from public database. The differentially expressed genes (DEGs) were screened using Limma package in R software. The biological functions of DEGs were shown by Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA). Protein-protein interaction (PPI) network was mapped in Cytoscape, followed by screening of hub genes based on the Molecular Complex Detection (MCODE) plug-in. Functional Enrichment analysis tool (FunRich) and Database for Annotation, Visualization and Integrated Discovery (DAVID) were used to predict miRNAs and TFs, respectively. Finally, GSE60993 expression matrix was chosen to plot receiver operating characteristic (ROC) curves with the aim of further assessing the reliability of our findings. Results. We obtained 176 DEGs and further identified 16 hub genes by MCODE. The results of functional enrichment analysis showed that DEGs mediated inflammatory response and immune-related pathways. Among the predicted miRNAs, hsa-miR-4770, hsa-miR-5195, and hsa-miR-6088 all possessed two target genes, which might be closely related to the development of ACS. Moreover, we identified 11TFs regulating hub gene transcriptional processes. Finally, ROC curves confirmed three genes with high confidence (area under the curve>0.9), including VEGFA, SPP1, and VCAM1. Conclusion. This study suggests that three genes (VEGFA, SPP1, and VCAM1) were involved in the molecular mechanisms of ACS pathogenesis and could serve as biomarkers of disease progression.

17 July 2026 in Medicine
Verified
Journal Article
Open access
CCCangsong Chen
Cangsong Chen
MLMingshuang Li
Mingshuang Li
Rationale: Cat-scratch disease (CSD) typically presents as self-limited regional lymphadenopathy following a cat scratch or exposure. Its clinical features can mimic malignancy or tuberculosis, especially in elderly patients, leading to potential misdiagnosis. This report underscores the importance of considering CSD in elderly individuals with unexplained fever and atypical lymphadenopathy. Patient concerns: A 67-year-old woman presented with a 3-month history of left axillary swelling, accompanied by pain and fever for 3 days. Diagnoses: Axillary CSD was confirmed based on clinical presentation, exposure history, and lymph node biopsy findings. Interventions: The patient received compound sulfamethoxazole tablets as anti-infective therapy. Outcomes: Two weeks post-treatment, the patient was afebrile, and the surgical incision had healed. Lessons: This case highlights the diagnostic challenges of CSD in the elderly. Early lymph node biopsy and careful elicitation of exposure history are essential to avoid misdiagnosis, particularly with malignancy. Timely intervention can prevent unnecessary procedures and improve prognosis. Evaluation of confirmed cases should also include an assessment for potential extra-nodal spread to sites such as the liver, colon, and retina.

1 January 2026 in Mediators of Inflammation
Verified
Journal Article
Open access
CRConglin Ren
Conglin Ren
MLMingshuang Li
Mingshuang Li
CHCaijian He
Caijian He
KLKuanglin Li
Kuanglin Li
HYHuanhong Yang
Huanhong Yang
Background: Triptolide demonstrates potent antiarthritic effects in rheumatoid arthritis (RA), although its complete mechanism is not fully elucidated. This study aimed to systematically identify its core targets and regulatory pathways by integrating network pharmacology, molecular docking, and experimental validation. Methods: Potential targets of triptolide and RA‐associated genes were sourced from public databases. Network module analysis identified key targets, the binding affinity of which to triptolide was subsequently assessed by molecular docking, molecular dynamics (MD) simulations, and drug affinity responsive target stability (DARTS) assay. The functional effects of triptolide on RA fibroblast‐like synoviocytes (RA‐FLS) behavior, joint inflammation, and bone erosion were further investigated using in vitro cellular assays and a collagen‐induced arthritis (CIA) mouse model. Results: Our analysis identified 73 candidate targets for triptolide against RA, which were primarily enriched in biological processes such as transcription factor activity and inflammatory response. Protein–protein interaction (PPI) network analysis highlighted a core module of five genes, among which STAT3 and its upstream regulator NR1D1 were selected for subsequent investigation. Molecular docking, MD simulation, and DARTS assay confirmed the high‐affinity and direct binding of triptolide to NR1D1. In vitro, triptolide effectively suppressed RA‐FLS migration and invasion, upregulated NR1D1, and inhibited JAK1/STAT3 signaling. In vivo, triptolide administration ameliorated arthritis severity and reduced bone erosion in CIA mice, as well as modulation of the NR1D1/STAT3 axis. Conclusion: This study demonstrates that triptolide alleviates RA through NR1D1‐mediated inhibition of JAK1/STAT3 signaling. Our findings elucidate a novel molecular mechanism for triptolide’s antiarthritic effects, thereby revealing the NR1D1/JAK1/STAT3 axis as a potential therapeutic target for RA.